Latest News - Stryker Corporation
Top Corporates Hub
Stryker Corporation
Stryker’s Pangea Europe Launch And What It Means For NYSE SYK Investors
10.06.2026 02:11
Stryker (NYSE:SYK) has introduced its Pangea Plating System trauma platform to the European market. The launch marks an extension of a product line that was previously available in North America. The system is designed to support fracture fixation and deepen collaboration with orthopedic surgeons in Europe. Stryker operates at the intersection of medical devices and orthopedics, where trauma implants are a core part of the business. Bringing the Pangea Plating System to Europe adds another...
Medtronic: The Turnaround Is Quietly Working
06.06.2026 04:30
Medtronic (MDT) outlook: mid-single-digit growth, stabilizing margins, and new drivers (Hugo, Affera). Read here for a detailed analysis.
Why Is Insulet (PODD) Down 8.7% Since Last Earnings Report?
05.06.2026 15:30
Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stryker Unveils TPX HD As Stock Trades Below Analyst Targets
04.06.2026 08:15
Stryker (NYSE:SYK) has introduced TPX HD, a next-generation surgical power tool for demanding orthopedic procedures. The system is designed to offer higher torque, customizable control, and improved ergonomics for revision and minimally invasive surgeries. This launch adds a new product to Stryker's existing orthopedic portfolio and follows earlier product and cybersecurity updates. Stryker's new TPX HD system arrives as the stock trades at around $295.0, with the share price down 15.3%...
Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?
02.06.2026 14:29
Globus Medical is riding musculoskeletal market growth with spine, trauma and ortho gains, strong cash flow and a debt-free balance sheet.
Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
02.06.2026 13:03
Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its TPX HD, a premium small bone power tool designed to support performance, control and ergonomics in a wide range of challenging orthopaedic procedures such as total joint revisions, minimally invasive surgery and oral maxillofacial procedures.
Boston Scientific Stock: Is BSX Underperforming the Healthcare Sector?
02.06.2026 03:12
Boston Scientific has considerably underperformed its sector peers recently, yet analysts remain highly optimistic about the stock’s prospects.
GMED's Robotics Leasing Shift Could Build Recurring Revenue
29.05.2026 13:52
Globus Medical is shifting robotics deals to leases and rentals, aiming to expand its installed base and build recurring revenue streams.
Is Stryker (SYK) Reframing Its Innovation Edge With Pangea And Cybersecurity Investments?
29.05.2026 11:04
Stryker recently launched its Pangea Plating System in Europe, a surgeon‑collaborated trauma platform designed to stabilize a wide range of fracture patterns across upper and lower extremities. The system’s use of global anatomical data and variable‑angle plating underscores Stryker’s push to tailor fracture fixation solutions to diverse patient populations and surgeon preferences. Next, we’ll explore how this European Pangea launch, alongside recent cyberattack disclosures, could influence...
Assessing Stryker (SYK) Valuation After Mixed Q1 Results And Cyberattack Concerns
29.05.2026 02:05
Stryker (SYK) is back in focus after mixed first quarter results, a disruptive cyberattack, and a series of analyst updates, even as the company rolls out new products and reorganizes parts of its business. See our latest analysis for Stryker. At a share price of US$307.63, Stryker’s short term share price return has been weak, with the stock down 20.6% over the past 90 days. The 5 year total shareholder return of 29.73% points to longer term gains and suggests recent momentum has faded as...
GMED Growth Drivers After NuVasive and What Q1 Signals
28.05.2026 13:22
Globus Medical's Q1 showed margin gains, strong spine and trauma growth, and rising robotics adoption as NuVasive synergies support 2026 targets.
Stryker Launches Pangea Plating System and Completes First Case in Europe
26.05.2026 06:10
AMSTERDAM, May 26, 2026--Stryker announced the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns.
Stryker Expands Peripheral Vascular Reach With Amplitude Deal And Undervalued Shares
22.05.2026 01:15
Stryker (NYSE:SYK) has agreed to acquire Amplitude Vascular Systems. The deal adds hydraulic intravascular lithotripsy technology aimed at treating calcified peripheral arterial disease. The transaction is intended to expand Stryker's peripheral vascular portfolio and support its medical technology focus. Stryker, trading at around $313.5, is using this acquisition to build out its peripheral vascular offerings at a time when calcified peripheral arterial disease remains a difficult area of...
Stryker’s chief accounting officer to retire
21.05.2026 11:06
William Berry Jr. will retire in September, with Corporate Controller Emily Baculik stepping into the role.
Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trends
21.05.2026 10:42
The healthcare team covers Q1 results from pharma and medtech companies and provides a wrap-up of the key takeaways.
Is Wall Street Bullish or Bearish on Stryker Corporation Stock?
20.05.2026 06:19
Stryker stock has underperformed the broader market over the past year, but analysts remain highly bullish about its prospects.
Stryker: Investors May Have Overreacted To Q1 Weakness
20.05.2026 02:34
Stryker's integrated 'Smart Hospital' strategy deepens customer lock-in, creating high switching costs and stable long-term demand. See why SYK stock is a Hold.
1 Oversold Stock Set for a Comeback and 2 That Underwhelm
19.05.2026 11:00
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem
19.05.2026 09:30
CHARLEVOIX, Mich., May 19, 2026--BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, Stryker (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in the